← FDA DRUG APPROVALS

FDA ANDA · ANDA078773

ATORVASTATIN CALCIUM

Sponsor: TEVA PHARMS

APPLICATION
ANDA078773
TYPE
ANDA
ORIGINAL APPROVAL
2012-05-29
LATEST ACTION
2012-05-29
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 80MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 20MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 40MG BASE · TABLET · ORAL
ATORVASTATIN CALCIUMDiscontinued
ATORVASTATIN CALCIUM EQ 10MG BASE · TABLET · ORAL

Approval history

2012-05-29Original — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →